Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

46 та иш

Иш: Design of competitive inhibitory peptides for HMG-CoA reductase and modeling structural preference for short linear peptides

  1. Syrian Hamster 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Expressed in Escherichia coli: Production of Homogeneous Protein

    Kenneth Frimpong, Bryant G. Darnay, V.W. Rodwell

    Мақола19934 иқтибос
    ABI

  2. Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes

    F. William Studier, Barbara A. Moffatt

    Мақола19864 иқтибос
    ABI

  3. Biomedical applications of dipeptides and tripeptides

    Sara Santos, Inês M. Torcato, Miguel A. R. B. Castanho

    Шарҳ мақола20124 иқтибос
    ABI

  4. Structure-Based Drug Design: Docking and Scoring

    Romano T. Kroemer

    Шарҳ мақола20074 иқтибос
    ABI

  5. The Natural Products as Hydroxymethylglutaryl-Coa Reductase Inhibitors

    Hayrettin Ozan Gülcan, Serkan Yiğitkan, İlkay Erdoğan Orhan

    Мақола20184 иқтибос
    ABI

  6. Inhibitor design for <scp>3‐hydroxy‐3‐methyl‐glutaryl‐CoA</scp> reductase enzyme; molecular docking and determination of molecular and electronic properties of ligands by density functional theory method

    Selami Ercan, Ercan Çınar, Cihat Özaydın +2

    Мақола20204 иқтибос
    ABI

  7. In vitro and in silico studies of 3-hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitory activity of the cowpea Gln-Asp-Phe peptide

    Mariana Silva, Caio Souza, Biane Oliveira Philadelpho +7

    Мақола20184 иқтибос
    ABI

  8. IAF, QGF, and QDF Peptides Exhibit Cholesterol-Lowering Activity through a Statin-like HMG-CoA Reductase Regulation Mechanism: In Silico and In Vitro Approach

    Mariana Silva, Biane Oliveira Philadelpho, Johnnie Elton Machado dos Santos +9

    Мақола20214 иқтибос
    ABI

  9. Hypercholesterolemia As a Risk Factor for Cardiovascular Disease: Current Controversial Therapeutic Management

    Arturo Zárate, Leticia Manuel‐Apolinar, Renata Saucedo +2

    Шарҳ мақола20163 иқтибос
    ABI

  10. Molecular aspects of hypercholesterolemia treatment: current perspectives and hopes

    Najmeh Ahangari, Majid Ghayour‐Mobarhan, Amirhossein Sahebkar +1

    Шарҳ мақола20183 иқтибос
    ABI

  11. Incidence of Cardiovascular Disease in Patients with Familial Hypercholesterolemia Phenotype: Analysis of 5 Years Follow-Up of Real-World Data from More than 1.5 Million Patients

    L. Masana, Alberto Zamora, Núria Plana +9

    Мақола20193 иқтибос
    ABI

  12. Inhibition of 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase enzyme by dipeptides identified in dry-cured ham

    Alejandro Heres, Leticia Mora, Fidel Toldrá

    Мақола20213 иқтибос
    ABI

  13. Statistical Methods for Research Workers.

    F. J. Anscombe, Ronald Aylmer Fisher

    Мақола19552 иқтибос
    ABI

  14. Сарлавҳасиз

    Бошқа2 иқтибос
    ABI

  15. Energy Component Analysis of π Interactions

    C. David Sherrill

    Мақола20122 иқтибос
    ABI

  16. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  17. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  18. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  19. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  20. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  21. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI